Description

Omnipaque Contrast Media

OMNIPAQUE ™ (iohexol) injection is a nonionic, x-ray or radiographic contrast medium for intrathecal, intravenous, oral, rectal and body cavity use.

Iohexol (radiopaque) Uses:

• Imaging: Adults:

  • Intrathecal:

    • Iohexol 180, 240, and 300: contrast enhancement for CT (myelography, cisternography, ventriculography), and Myelography (lumbar, thoracic, cervical, and total columnar)

  • ---

    Intravascular:

    • Iohexol 140:

      • Intra-arterial digital subtraction angiography of head, neck, abdominal, renal, and peripheral vessels

    • Iohexol 240:

      • Contrast enhancement for CT head imaging and peripheral venography (phlebography)

    • Iohexol 300:

      • for Aortography (including studies of the arch of aorta, abdominal aorta, and its branches], contrast enhancement for CT head and body, peripheral venography i.e phlebography, cerebral arteriography, and excretory urography

    • Iohexol 350:

      • Angiocardiography (ventriculography, selective coronary arteriography), contrast enhancement for CT head and body, aortography (including studies of the root of the aorta, arch of aorta, ascending aorta, abdominal aorta [and branches]), intravenous digital subtraction angiography of head, neck, abdominal renal and peripheral vessels, peripheral arteriography, and excretory urography

    • Iohexol 300 (bulk) and 350 (bulk):

      • Contrast enhancement for CT head and body imaging (for IV administration with an appropriate automated contrast injection system, contrast management system, or contrast media transfer set)

  • ---

    Oral:

    • Iohexol 350:

      • Oral radiography examination of the gastrointestinal tract

  • Oral in conjunction with IV administration:

    • Iohexol 240, 300, and 350 (diluted; oral) and Iohexol 300 (IV):

      • Contrast-enhanced abdomen CT

    • Iohexol (oral solution 9 and 12) and Iohexol 300 (IV):

      • Contrast-enhanced abdomen CT

  • Intraarticular:

    • Iohexol 240, 300, and 350: Arthrography

  • Body cavity:

    • Iohexol 240:

      • Endoscopic retrograde pancreatography (ERP) and cholangiopancreatography (ERCP), herniography, and hysterosalpingography

    • Iohexol 300:

      • Hysterosalpingography

  • ---

    Oral:

    • Iohexol (Oraltag):

      • Contrast enhancement for CT abdomen and pelvis imaging to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology
  • Limitations of use:
    • Oraltag is not indicated for diagnostic examination of the GI tract.

• ---

  Imaging: Pediatrics:

  • Intrathecal:

    • Iohexol 180:

      • Myelography (lumbar, thoracic, cervical, and total columnar), and contrast enhancement for CT (myelography, cisternography)
  • Intravascular:

    • Iohexol 240:

      • Contrast enhancement for CT head and body imaging

    • Iohexol 300:

      • Angiocardiography (ventriculography), contrast enhancement for CT head and body imaging, and excretory urography

    • Iohexol 350:

      • Angiocardiography (ventriculography, pulmonary arteriography, venography, and studies of collateral arteries);
      • aortography, including the root of aorta, arch of aorta, ascending and descending aorta)

    • Iohexol 300 (bulk):

      • Contrast enhancement for CT head and body imaging (for IV administration with an appropriate automated contrast injection system, contrast management system, or contrast media transfer set)

  • Oral or rectal:

    • Iohexol 180, 240, and 300:

      • Oral and rectal radiographic examination of the gastrointestinal tract

  • Oral in conjunction with IV administration:

    • Iohexol 240, 300, and 350 (diluted; oral) and Iohexol 240 or 300 (IV):

      • Contrast-enhanced abdomen CT

    • Iohexol (oral solution 9 and 12) and Iohexol 240 or 300 (IV):

      • Contrast-enhanced abdomen CT

  • Body cavity:

    • Iohexol 240, 300, and 350 (diluted):

      • Voiding cystourethrography (VCUG)

  • Oral:

    • Iohexol (Oraltag):

      • Contrast enhancement for CT abdomen and pelvis imaging to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology

  • Limitations of use:

    • Oraltag is not indicated for diagnostic examination of the GI tract.